SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt

被引:9
|
作者
Zhao, Jian [1 ]
Xu, Jian [1 ]
Zhang, Rui [1 ]
机构
[1] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Colorectal Surg, 44 Xiaoheyan Rd, Shenyang 110042, Liaoning, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2018年 / 10卷 / 02期
关键词
SRPX2; miR-192; miR-215; colon cancer; PI3K-Akt; GASTRIC-CANCER; COLORECTAL-CANCER; MICRORNA-192; SUPPRESSES; MIR-215; GLIOBLASTOMA; PROGRESSION; METASTASIS; EXPRESSION; DISORDERS; PROGNOSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colon cancer is one of common cancer in the world and glycolysis is one of the major problems in colon cancer therapy. MicroRNAs (miRNAs) involve in colon cancer progression. Sushi repeat-containing protein X-linked 2 (SRPX2) is associated with poor prognosis in some cancer patients, however, the role of SRPX2 including glycolytic metabolism regulated by miRNAs is unclear in colon cancer. So, the purpose of the present study is to elucidate the underlying mechanism in colon cancer metabolism mediated by SRPX2. Our results revealed that miR-192-5p (miR-192) and miR-215-5p (miR-215) inhibited glycolysis by regulating SRPX2 expression in colon cancer cells. We also found that miR-192 and miR-215 were both regulated by PI3K-Akt. Our results indicate that SRPX2 facilitates colon cancer cell glycolysis by miR-192 and miR-215, which are down-regulated by PI3K-Akt.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 50 条
  • [11] HER2 Expression and PI3K-Akt Pathway Alterations in Gastric Cancer
    Sukawa, Yasutaka
    Yamamoto, Hiroyuki
    Nosho, Katsuhiko
    Ito, Miki
    Igarashi, Hisayoshi
    Naito, Takafumi
    Mitsuhashi, Kei
    Matsunaga, Yasutaka
    Takahashi, Taiga
    Mikami, Masashi
    Adachi, Yasushi
    Suzuki, Hiromu
    Shinomura, Yasuhisa
    DIGESTION, 2014, 89 (01) : 12 - 17
  • [12] IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis
    Ruan, Hong-xun
    Qin, Xiao-ning
    Huang, Wei
    Lin, Lin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [13] miR-196b regulates gastric cancer cell proliferation and invasion via PI3K/AKT/mTOR signaling pathway
    Li, Na
    Wang, Weiqiang
    Xu, Bin
    Gong, Hongyun
    ONCOLOGY LETTERS, 2016, 11 (03) : 1745 - 1749
  • [14] PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer
    Karim, Shahid
    Burzangi, Abdulhadi S.
    Ahmad, Aftab
    Siddiqui, Nasir Ali
    Ibrahim, Ibrahim M.
    Sharma, Priyanka
    Abualsunun, Walaa A.
    Gabr, Gamal A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [15] HNRNPD is a prognostic biomarker in non-small cell lung cancer and affects tumor growth and metastasis via the PI3K-AKT pathway
    Fan, Guoqing
    Li, Danni
    Liu, Jingjing
    Tao, Ningning
    Meng, Chao
    Cui, Ju
    Cai, Jianping
    Sun, Tieying
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (03) : 1571 - 1590
  • [16] E2+norethisterone promotes the PI3K-AKT pathway via PGRMC1 to induce breast cancer cell proliferation
    Zhang, L.
    Ruan, X.
    Gu, M.
    Mueck, A. O.
    CLIMACTERIC, 2022, 25 (05) : 467 - 475
  • [17] SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer
    Li, Guodong
    Hu, Fuqing
    Luo, Xuelai
    Hu, Junbo
    Feng, Yongdong
    PEERJ, 2017, 5
  • [18] miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway
    Cao, Weiguo
    Yang, Weiping
    Fan, Rong
    Li, Hao
    Jiang, Jinsong
    Geng, Mei
    Jin, Yening
    Wu, Yunlin
    TUMOR BIOLOGY, 2014, 35 (02) : 1287 - 1295
  • [19] miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT
    Liu, H-Y
    Zhang, Y-Y
    Zhu, B-L
    Feng, F-Z
    Yan, H.
    Zhang, H-Y
    Zhou, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (10) : 4149 - 4155
  • [20] LINC00342 regulates the PI3K-AKT signaling pathway via the miR-149-5p/FGF11 axis and affects the progression of oral cancer
    Chen, Yimiao
    Wang, Yanchun
    Zhang, Wenbo
    DISCOVER ONCOLOGY, 2024, 15 (01)